INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "HYDROQUINAZOLINE DERIVATIVES AND TREATMENT OF A DISEASE OR DISORDER USING THE SAME"

GENEVA, March 9 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/058663) for "HYDROQUINAZOLINE DERIVATIVES AND TREATMENT OF A DISEASE OR DISORDER USING THE SAME" on Aug 27, 2025. With publication no. WO/2026/047577, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANGST, Daniela (Novartis Pharma AGLichtstrasse 354056 Basel), SHAW, Duncan E. (Novartis Pharma AGLichtstrasse 354056 Basel), BOLDUC, Philippe (324 East St.Weymouth, Massachusetts 02189), CARSON, Matthew William (Novartis Institute...